ArticleFrontiers in immunology2022

A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.

Jingxian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.